R.H. Bluestein & Co’s Cavium, Inc. CAVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-3,000
Closed -$260K 336
2018
Q2
$260K Hold
3,000
0.01% 266
2018
Q1
$238K Hold
3,000
0.01% 288
2017
Q4
$251K Buy
+3,000
New +$232K 0.01% 280
2017
Q2
Sell
-3,000
Closed -$215K 351
2017
Q1
$215K Buy
+3,000
New +$201K 0.01% 295
2016
Q1
Sell
-5,000
Closed -$329K 324
2015
Q4
$329K Hold
5,000
0.02% 197
2015
Q3
$307K Hold
5,000
0.02% 222
2015
Q2
$344K Hold
5,000
0.02% 236
2015
Q1
$354K Hold
5,000
0.02% 230
2014
Q4
$309K Hold
5,000
0.02% 272
2014
Q3
$249K Hold
5,000
0.02% 318
2014
Q2
$248K Hold
5,000
0.01% 316
2014
Q1
$219K Buy
+5,000
New +$196K 0.01% 323
2013
Q4
Sell
-5,000
Closed -$206K 386
2013
Q3
$206K Buy
+5,000
New +$188K 0.01% 316

R.H. Bluestein & Co's CAVM Position: Q3 2018 in Review

R.H. Bluestein & Co sold out of Cavium, Inc. (CAVM) in Q3 2018, closing a stake of 3,000 shares — an estimated $260K sold.

R.H. Bluestein & Co first reported a position in CAVM in Q3 2013 and held it in 13 quarters. The position peaked at $354K in Q1 2015. 0 funds tracked by Wall St. Rank hold CAVM as of Q3 2018.

  • R.H. Bluestein & Co reported no remaining Cavium, Inc. position as of Q3 2018 after selling out during the quarter.
  • R.H. Bluestein & Co sold 3,000 Cavium, Inc. shares in Q3 2018, an estimated $260K.
  • R.H. Bluestein & Co first reported a position in Cavium, Inc. in Q3 2013 and held it in 13 quarters.
  • R.H. Bluestein & Co's Cavium, Inc. position peaked at $354K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held Cavium, Inc. as of Q3 2018.

Based on R.H. Bluestein & Co's 13F filing for Q3 2018, filed 13 Nov 2018.